Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) As first-line therapy for patients with colorectal cancer

Yasuhide Yamada, Atsushi Ohtsu, Narikazu Boku, Yoshinori Miyata, Yasuhiro Shimada, Toshihiko Doi, Kei Muro, Manabu Muto, Tetsuya Hamaguchi, Kiyomi Mera, Tomonori Yano, Yusuke Tanigawara, Kuniaki Shirao

    Research output: Contribution to journalArticle

    9 Scopus citations

    Fingerprint Dive into the research topics of 'Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) As first-line therapy for patients with colorectal cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences